These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 385585)

  • 21. Tiapride in the treatment of tardive dyskinesia: a clinical and biochemical study.
    Perényi A; Arató M; Bagdy G; Frecska E; Szücs R
    J Clin Psychiatry; 1985 Jun; 46(6):229-31. PubMed ID: 2860098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral choline administration to patients with tardive dyskinesia.
    Growdon JH; Hirsch MJ; Wurtman RJ; Wiener W
    N Engl J Med; 1977 Sep; 297(10):524-7. PubMed ID: 887103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-dose valproate: a new treatment for cyclothymia, mild rapid cycling disorders, and premenstrual syndrome.
    Jacobsen FM
    J Clin Psychiatry; 1993 Jun; 54(6):229-34. PubMed ID: 8331092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diazepam-induced changes in tardive dyskinesia: suggestions for a new conceptual model.
    Singh MM; Becker RE; Pitman RK; Nasrallah HA; Lal H; Dufresne RL; Weber SS; McCalley-Whitters M
    Biol Psychiatry; 1982 Jun; 17(6):729-42. PubMed ID: 6125219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of valproic acid on an animal model of tardive dyskinesia.
    Peixoto MF; Abílio VC; Silva RH; Frussa-Filho R
    Behav Brain Res; 2003 Jun; 142(1-2):229-33. PubMed ID: 12798284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A therapeutic approach to tardive dyskinesia.
    Fahn S
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):19-24. PubMed ID: 2858474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroleptic-induced tardive dyskinesia.
    Jenner P; Marsden CD
    Acta Psychiatr Belg; 1987; 87(5):566-98. PubMed ID: 2897761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapeutic trial of gamma-vinyl GABA, an inhibitor of GABA transaminase, in tardive dyskinesias induced by neuroleptics].
    Lambert PA; Cantiniaux P; Chabannes JP; Tell GP; Schechter PJ; Koch-Weser J
    Encephale; 1982; 8(3):371-6. PubMed ID: 6137357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clozapine in tardive dyskinesia: observations from human and animal model studies.
    Tamminga CA; Thaker GK; Moran M; Kakigi T; Gao XM
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():102-6. PubMed ID: 7961550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxiperomide in tardive dyskinesia.
    Casey DE; Gerlach J
    J Neurol Neurosurg Psychiatry; 1980 Mar; 43(3):264-7. PubMed ID: 7373324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Tardive dyskinesia. Synthetic-critical review and case contribution].
    Campanini T; Catalano A; De Risio C; Forino V
    Ateneo Parmense Acta Biomed; 1977; 48(1):41-60. PubMed ID: 324489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variable clinical response to choline in tardive dyskinesia.
    Nasrallah HA; Dunner FJ; Smith RE; McCalley-Whitters M; Sherman AD
    Psychol Med; 1984 Aug; 14(3):697-700. PubMed ID: 6387757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GABA system: clinical research and treatment of tardive dyskinesia.
    Thaker GK; Hare TA; Tamminga CA
    Mod Probl Pharmacopsychiatry; 1983; 21():155-67. PubMed ID: 6419061
    [No Abstract]   [Full Text] [Related]  

  • 34. Symptom control in tardive dyskinesia.
    Crowe BM
    Br J Psychiatry; 1983 Oct; 143():419-20. PubMed ID: 6414567
    [No Abstract]   [Full Text] [Related]  

  • 35. Prolactin response to sodium valproate in schizophrenics with and without tardive dyskinesia.
    Monteleone P; Maj M; Ariano MG; Iovino M; Fiorenza L; Steardo L
    Psychopharmacology (Berl); 1988; 96(2):223-6. PubMed ID: 3148149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin E in the treatment of tardive dyskinesia: a preliminary study over 7 months at different doses.
    Sajjad SH
    Int Clin Psychopharmacol; 1998 Jul; 13(4):147-55. PubMed ID: 9727725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological modification of experimental tardive dyskinesia.
    Bárány S; Gunne LM
    Acta Pharmacol Toxicol (Copenh); 1979 Aug; 45(2):107-11. PubMed ID: 115227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pilot study of cyproheptadine (Periactin) in tardive dyskinesia [proceedings].
    Gardos G; Cole JO
    Psychopharmacol Bull; 1978 Apr; 14(2):18-20. PubMed ID: 349599
    [No Abstract]   [Full Text] [Related]  

  • 39. Linear relationship between plasma concentration and dosage of sodium valproate.
    Nutt JG; Kupferberg HJ
    Epilepsia; 1979 Dec; 20(6):589-92. PubMed ID: 387391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blepharospasm--successful treatment with baclofen and sodium valproate. A case report.
    Sandyk R
    S Afr Med J; 1983 Dec; 64(24):955-6. PubMed ID: 6417803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.